In the atorvastatin 10-mg group , tertile 3 was associated with a higher risk of MACE compared to the first tertile ( HR : 2.08 ; 95 % CI : 1.20 to 3.61 ; p = 0.01 ) but this was not significant in the atorvastatin 80-mg group ( HR : 1.40 ; 95 % CI : 0.80 to 2.46 ; p = 0.24 ) .